Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using bioinformatics for drug target identification from the genome.

American journal of pharmacogenomics : genomics-related research in drug development and clinical practice - 1 Jan 2005

Jiang Zhenran, Zhou Yanhong

Abstract excerpt

Genomics and proteomics technologies have created a paradigm shift in the drug discovery process, with bioinformatics having a key role in the exploitation of genomic, transcriptomic, and proteomic data to gain insights into the molecular mechanisms that underlie disease and to identify potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Genetic
Share to Drug Delivery Systems
Share to Drug Design

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ion Channels

Share to Molecular Biology

Share to Receptors, Cytoplasmic and Nuclear

Share to Receptors, G-Protein-Coupled

Share to Xenobiotics

Source

Identifiers

PMID: 16336003
DOI: 10.2165/00129785-200505060-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16336003-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using bioinformatics for drug target identification from the genome.PMID 16336003Read ↗

A comprehensive map of molecular drug targets.Semantic proximity Read ↗

Systems biology approach for new target and biomarker identification.Semantic proximity Read ↗

The role of emerging genomics and proteomics technologies in cancer drug target discovery.Semantic proximity Read ↗

Exploration of target spaces in the human genome for protein and peptide drugsSemantic proximity Read ↗

Drug target identification: a question of biology.Semantic proximity Read ↗

Open Targets: Mining gene and disease associations for improved drug target identificationSemantic proximity Read ↗

Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.Semantic proximity Read ↗

Assessing drug target suitability using TargetMineSemantic proximity Read ↗

Drug repositioning using disease associated biological processes and network analysis of drug targets.Semantic proximity Read ↗

Druggability of human disease genes.Semantic proximity Read ↗

Bridging the gap between target-based and phenotypic-based drug discovery.Semantic proximity Read ↗

Emerging uses for genomic information in drug discovery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.